Literature DB >> 9808312

Intracranial vascular stenosis and occlusion: comparison of 3D time-of-flight and 3D phase-contrast MR angiography.

M Oelerich1, M G Lentschig, P Zunker, P Reimer, E J Rummeny, G Schuierer.   

Abstract

We compared the value of 3D time-of-flight (TOF) and phase-contrast (PC) MR angiography (MRA) for detection and grading of intracranial vascular steno-occlusive disease. Unenhanced 3D-TOF MRA and 3D-PC MRA (30-60 cm/s velocity encoding) were performed at the level of the circle of Willis in 18 patients, mean age 56 +/- 10 years. Postprocessed images using a maximum-intensity projection reconstruction with multiple targetted projections were analysed. A total of 126 vessels was assessed by PC MRA and 143 by TOF MRA, with digital subtraction angiography (DSA) in 15 patients and/or transcranial Doppler sonography (TCD) in 18 as a standard. Two blinded readers reviewed the MRA, DSA and TCD examinations retrospectively. On DSA and/or TCD the two observers found 32 and 28 steno-occlusive lesions. 3D-TOF MRA was more sensitive than 3D-PC MRA (87% and 86% vs. 65% and 60%) and had a higher negative predictive value (96% vs. 89%). Correct grading of stenoses was achieved in 78 % by 3D-TOF and 65% by 3D-PC MRA.

Entities:  

Mesh:

Year:  1998        PMID: 9808312     DOI: 10.1007/s002340050645

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  24 in total

Review 1.  Advances in non-invasive imaging of intracranial vascular disease.

Authors:  H R Jäger; J P Grieve
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

Review 2.  MR angiography of the intracranial vessels: technical aspects and clinical applications.

Authors:  Ozkan Ozsarlak; Johan W Van Goethem; Menno Maes; Paul M Parizel
Journal:  Neuroradiology       Date:  2004-12-04       Impact factor: 2.804

3.  HYPR TOF: time-resolved contrast-enhanced intracranial MR angiography using time-of-flight as the spatial constraint.

Authors:  Yijing Wu; Steven R Kecskemeti; Kevin Johnson; Kang Wang; Howard Rowley; Oliver Wieben; Charles Mistretta; Patrick Turski
Journal:  J Magn Reson Imaging       Date:  2011-02-01       Impact factor: 4.813

4.  Composite MRA: statistical approach to generate an MR angiogram from multiple contrasts.

Authors:  Dahan Kim; Myriam Edjlali; Patrick Turski; Kevin M Johnson
Journal:  Magn Reson Med       Date:  2019-09-25       Impact factor: 4.668

5.  MR imaging and angiography of primary CNS vasculitis of childhood.

Authors:  R I Aviv; S M Benseler; E D Silverman; P N Tyrrell; G Deveber; L M Tsang; D Armstrong
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

6.  [Modern cross-sectional imaging of head and neck vessels].

Authors:  K Papke; F Brassel
Journal:  Radiologe       Date:  2010-04       Impact factor: 0.635

7.  Angiography of primary central nervous system angiitis of childhood: conventional angiography versus magnetic resonance angiography at presentation.

Authors:  R I Aviv; S M Benseler; G DeVeber; E D Silverman; P N Tyrrell; L M Tsang; D Armstrong
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

8.  Non-contrast MR angiography versus contrast enhanced MR angiography for detection of renal artery stenosis: a comparative analysis in 400 renal arteries.

Authors:  Hira Lal; Rani Kunti Randhir Singh; Priyank Yadav; Ankusha Yadav; Dharmendra Bhadauria; Anuradha Singh
Journal:  Abdom Radiol (NY)       Date:  2020-11-02

9.  Central nervous system angiitis: a series of 31 patients.

Authors:  Guillaume Geri; David Saadoun; Rémy Guillevin; Sophie Crozier; Catherine Lubetzki; Karima Mokhtari; Zahir Amoura; Bertrand Wechsler; Du Le Boutin; Nathalie Costedoat-Chalumeau; Yves Samson; Patrice Cacoub
Journal:  Clin Rheumatol       Date:  2013-10-06       Impact factor: 2.980

10.  Magnetic resonance angiography in suspected cerebral vasculitis.

Authors:  Philippe Demaerel; Nele De Ruyter; Frederik Maes; Beatrijs Velghe; Guido Wilms
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.